Advanced Biomedical (ABMT) 10-Q 19 Jun 18 2018 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Apr. 30, 2018	Jun. 19, 2018
Document And Entity Information
Entity Registrant Name	Advanced Biomedical Technologies Inc.
Entity Central Index Key	1,385,799
Document Type	10-Q
Document Period End Date	Apr. 30, 2018
Amendment Flag	false
Current Fiscal Year End Date	--10-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		69,374,850
Trading Symbol	ABMT
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,018

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Apr. 30, 2018	Oct. 31, 2017
CURRENT ASSETS
Cash and cash equivalents	$ 13,485	$ 7,463
Other receivables and prepaid expenses	20,329	17,469
Total Current Assets	33,814	24,932
Property and equipment, cost	511,158	483,482
Less: Accumulated depreciation	(447,036)	(422,967)
PROPERTY AND EQUIPMENT, NET	64,122	60,515
LONG-TERM PREPAID EXPENSES, NET	31,488
TOTAL ASSETS	129,424	85,447
CURRENT LIABILITIES
Other payables and accrued expenses	439,424	409,079
Due to directors	322,514	321,420
Due to a stockholders	669,571	582,795
Due to related parties	4,333,783	3,767,180
Total Current Liabilities	5,765,292	5,080,474
STOCKHOLDERS' DEFICIT
Common stock, $0.00001 par value, 100,000,000 shares authorized, 69,374,850 issued and outstanding as of April 30, 2018 and October 31, 2017	694	694
Additional paid-in capital	2,681,261	2,673,620
Accumulated deficit	(8,110,660)	(7,679,298)
Accumulated other comprehensive (loss)/income	(207,163)	9,957
Total Deficit	(5,635,868)	(4,995,027)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 129,424	$ 85,447

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Apr. 30, 2018	Oct. 31, 2017
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	69,374,850	69,374,850
Common stock, shares outstanding	69,374,850	69,374,850

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Apr. 30, 2018	Apr. 30, 2017	Apr. 30, 2018	Apr. 30, 2017
OPERATING EXPENSES
General and administrative expenses	$ 118,298	$ 100,238	$ 239,970	$ 169,861
Depreciation	2,338	3,619	4,517	8,285
Research and development	7,956	12,977	23,726	27,276
Total Operating Expenses	128,592	116,834	268,213	205,422
LOSS FROM OPERATIONS	(128,592)	(116,834)	(268,213)	(205,422)
OTHER (EXPENSES) INCOME
Interest income	14	6	21	16
Interest paid to a stockholder and related parties	(72,293)	(56,317)	(139,839)	(111,873)
Interest paid to a third party		(2,574)		(4,735)
Imputed interest	(3,797)	(3,927)	(7,641)	(8,020)
Other, net	(4,151)	(3,689)	(15,690)	(7,414)
Total Other Expenses, net	(80,227)	(66,501)	(163,149)	(132,026)
LOSS BEFORE TAXES	(208,819)	(183,335)	(431,362)	(337,448)
Income tax expense
NET LOSS	(208,819)	(183,335)	(431,362)	(337,448)
Net loss attributable to non-controlling interests
NET LOSS ATTRIBUTABLE TO ABMT COMMON STOCKHOLDERS	(208,819)	(183,335)	(431,362)	(337,448)
OTHER COMPREHENSIVE INCOME
Foreign currency translation income	38,298	7,485	(217,120)	65,715
Total other comprehensive loss	38,298	7,485	(217,120)	65,715
COMPREHENSIVE LOSS ATTRIBUTABLE TO ABMT COMMON STOCKHOLDERS	$ (170,521)	$ (175,850)	$ (648,482)	$ (271,733)
Net loss per share-basic and diluted - basic and diluted			$ (0.01)	$ (0.01)
Weighted average number of shares outstanding during the period - basic and diluted	69,374,850	67,200,693	69,374,850	67,162,142

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Total
Balance at Oct. 31, 2016	$ 671	$ 2,520,520	$ (6,987,698)	$ 104,212	$ (4,362,295)
Balance, shares at Oct. 31, 2016	67,124,850
Stock issued for debt conversion at 0.05 per shares	$ 20	99,980			100,000
Stock issued for debt conversion at 0.05 per shares, shares	2,000,000
Stock issued for services ($0.15 per share)	$ 3	37,497			37,500
Stock issued for services ($0.15 per share), shares	250,000
Imputed interest on advances from directors		15,623			15,623
Net loss for the period			(691,600)		(691,600)
Foreign currency translation loss				(94,255)	(94,255)
Balance at Oct. 31, 2017	$ 694	2,673,620	(7,679,298)	9,957	(4,995,027)
Balance, shares at Oct. 31, 2017	69,374,850
Stock issued for services ($0.15 per share)
Imputed interest on advances from directors		7,641			7,641
Net loss for the period			(431,362)		(431,362)
Foreign currency translation loss				(217,120)	(217,120)
Balance at Apr. 30, 2018	$ 694	$ 2,681,261	$ (8,110,660)	$ (207,163)	$ (5,635,868)
Balance, shares at Apr. 30, 2018	69,374,850

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) (Parenthetical)	Oct. 31, 2017$ / shares
Statement of Stockholders' Equity [Abstract]
Debt conversion price, per share	$ 0.05
Shares issued for service, per share	$ 0.15

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Apr. 30, 2018	Apr. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss attributable to ABMT common stockholders	$ (431,362)	$ (337,448)
Adjustments to reconcile net loss to cash used in
Depreciation	4,517	8,285
Amortization of long-term prepaid expenses	1,825
Stock issued for services		37,500
Imputed interest	7,641	8,020
Decrease (increase) in:
Other receivables and prepaid expenses	(2,219)	(1,352)
(Decrease) increase in:
Other payables and accrued expenses	13,114	94,322
Net cash used in operating activities	(406,484)	(190,673)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(5,256)
Renovation of factory premises	(32,854)
Decrease in deposit for purchase of property and equipment		1,198
Net cash used in investing activities	(38,110)	1,198
CASH FLOWS FROM FINANCING ACTIVITIES
Due to a stockholder	87,308	58,495
Due to directors	(12,925)	(26,437)
Due to related parties	376,056	186,810
Net cash provided by financing activities	450,439	218,868
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	177	(80)
NET INCREASE IN CASH AND CASH EQUIVALENTS	6,022	29,313
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF PERIOD	7,463	6,559
CASH AND CASH EQUIVALENTS AT THE END OF PERIOD	$ 13,485	$ 35,872

Basis of Presentation

Basis of Presentation	6 Months Ended
	Apr. 30, 2018
Accounting Policies [Abstract]
Basis of Presentation	NOTE 1 BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements contain adjustments considered necessary to present fairly the Company’s financial position as of April 30, 2018, the consolidated results of operations for the three and six months ended April 30, 2018 and 2017 and consolidated statements of cash flows for the six months ended April 30, 2018 and 2017 on an accrual basis and in accordance with accounting principles generally accepted in the United States of America for interim financial information and rules and regulations of the SEC. The consolidated results for the three and six months ended April 30, 2018 are not necessarily indicative of the results to be expected for the entire fiscal year ending October 31, 2018. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for the year ended October 31, 2017 appearing in the Company’s annual report on Form 10-K as filed with the Securities and Exchange Commission on February 13, 2018. The reporting currency of the Company is US dollar.

Organization

Organization	6 Months Ended
	Apr. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	NOTE 2 ORGANIZATION Advanced BioMedical Technologies, Inc. (fka “Geostar Mineral Corporation” or “Geostar”) (“ABMT”) was incorporated in Nevada on September 12, 2006. Shenzhen Changhua Biomedical Engineering Company Limited (“Shenzhen Changhua”) was incorporated in the People’s Republic of China (“PRC”) on September 25, 2002 as a limited liability company with a registered capital of $724,017. Shenzhen Changhua is owned by two stockholders in the proportion of 70% and 30% respectively. Shenzhen Changhua is a developer and manufacturer of polymer orthopaedic internal fixation devices. The Company is currently conducting clinical trials on its products and intends to raise additional capital to produce and market its products commercially. The Company’s Polymer Internal Fixation Screws has been approved by the China Food and Drug Administration (“CFDA”, fka “SFDA”) of the PRC in April 2018. The Company has no revenue since its inception and, in accordance with Accounting Standards Codification (“ASC”) Topic 915, “Development Stage Entities” (formerly Statement of Financial Accounting Standard (“SFAS”) No. 7, “Accounting and Reporting by Development Stage Enterprise”), is considered a Development Stage Company. Masterise Holdings Limited (“Masterise”) was incorporated in the British Virgin Islands on May 31, 2007 as an investment holding company and was then owned as to 63% by the spouse of Shenzhen Changhua’s 70% majority stockholder at the time and 37% by a third party corporation. On January 29, 2008, Masterise entered into a Share Purchase Agreement (“the Agreement”) with a stockholder of Shenzhen Changhua whereupon Masterise acquired 70% of Shenzhen Changhua for US$64,100 in cash. The acquisition was completed on February 25, 2008. As both Masterise and Shenzhen Changhua were under common control and management, the acquisition was accounted for as a reorganization of entities under common control. Accordingly, the operations of Shenzhen Changhua were included in the consolidated financial statements as if the transactions had occurred retroactively. On December 31, 2008, ABMT consummated a Share Exchange Agreement (“the Exchange Agreement”) with the stockholders of Masterise pursuant to which ABMT issued 50,000 shares of Common Stock to the stockholders of Masterise for 100% equity interest in Masterise. Concurrently, on December 31, 2008, a major stockholder of ABMT also consummated an Affiliate Stock Purchase Agreement (the “Affiliate Agreement”) with thirteen individuals including all the stockholders of Masterise, pursuant to which the major stockholder sold a total of 5,001,000 shares of ABMT’s common stock for a total aggregate consideration of $5,000, including 4,438,250 shares to the stockholders of Masterise. On consummation of the Exchange Agreement and the Affiliate Agreement, the 70% majority stockholder of Masterise became an 80.7% stockholder of ABMT. On March 13, 2009, the name of the Company was changed from Geostar Mineral Corporation to Advanced Biomedical Technologies, Inc. The merger of ABMT and Masterise was treated for accounting purposes as a capital transaction and recapitalization by Masterise (“the accounting acquirer”) and a re-organization by ABMT (“the accounting acquiree”). The financial statements have been prepared as if the re-organization had occurred retroactively. Accordingly, these financial statements include the following: (1) The balance sheet consisting of the net assets of the acquirer at historical cost and the net assets of the acquiree at historical cost. (2) The statement of operations including the operations of the acquirer for the periods presented and the operations of the acquiree from the date of the transaction. ABMT, Masterise and Shenzhen Changhua are hereinafter referred to as (“the Company”).

Principles of Consolidation

Principles of Consolidation	6 Months Ended
	Apr. 30, 2018
Accounting Policies [Abstract]
Principles of Consolidation	NOTE 3 PRINCIPLES OF CONSOLIDATION The accompanying condensed consolidated financial statements include the financial statements of ABMT and its wholly owned subsidiaries, Masterise and its 70% owned subsidiary, Shenzhen Changhua. The non-controlling interests in periods prior to 2012 represent the non-controlling stockholders’ 30% proportionate share of the results of Shenzhen Changhua. All significant inter-company balances and transactions have been eliminated in consolidation.

Use of Estimates

Use of Estimates	6 Months Ended
	Apr. 30, 2018
Use Of Estimates
Use of Estimates	NOTE 4 USE OF ESTIMATES The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Apr. 30, 2018
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 5 RELATED PARTY TRANSACTIONS As of April 30, 2018 and October 31, 2017, the Company owed a stockholder $669,571 and $582,795 respectively which are unsecured and repayable on demand. Interests are charged at 7% per annum on the amount owed. As of April 30, 2018 and October 31, 2017, the Company owed three related parties a total of $4,333,783 and $3,767,180 respectively which are unsecured and repayable on demand. Interests are charged at 7% per annum on the amounts owed. Total interest expenses on advances from a stockholder and the related parties accrued for the three and six months ended April 30, 2018 and 2017 were $72,293, $56,317, $139,839 and $111,873 respectively. As of April 30, 2018 and October 31, 2017, the Company owed $322,514 and $321,420 respectively, to two directors for advances made on an unsecured basis, repayable on demand and interest free. Imputed interest charged at 5% per annum on the amounts owed to two directors is $3,797, $3,927, $7,641 and $8,020 for the three and six months ended April 30, 2018 and 2017 respectively.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Apr. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 6 COMMITMENTS AND CONTINGENCIES The Company’s existing rental leases do not contain significant restrictive provisions. The schedule of future minimum lease obligations falling due under non-cancelable rental operating leases is as follows: Fiscal year ending October 31, 2018 7,580 Fiscal year ending October 31, 2019 7,580 Total $ 15,160

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Apr. 30, 2018
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	NOTE 7 FAIR VALUE OF FINANCIAL INSTRUMENTS The Financial Accounting Standards Board (FASB) Codification Topic 825 (ASC Topic 825), “Disclosure About Fair Value of Financial Instruments,” requires certain disclosures regarding the fair value of financial instruments. The carrying amounts of other receivables and prepaid expenses, other payables and accrued liabilities and due to a stockholder, directors and related parties approximate their fair values because of the short-term nature of the instruments. The management of the Company is of the opinion that the Company is not exposed to significant interest or credit risks arising from these financial statements.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	6 Months Ended
	Apr. 30, 2018
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	NOTE 8 RECENT ACCOUNTING PRONOUNCEMENTS Business Combination: Clarifying the Definition of a Business In January 2017, the FASB issued ASU No. 2017-1 “Topic 805, Business Combinations: Clarifying the Definition of a Business”. The amendments in this update provide a screen to determine when a set is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, the set is not a business. This screen reduces the number of transactions that need to be further evaluated. The amendments in this update affect all reporting entities that must determine whether they have acquired or sold a business. Public business entities should apply the amendments in this update to annual periods beginning after December 15, 2017, including interim periods within those periods. All other entities should apply the amendments to annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. The Company does not expect the adoption of ASU 2017-1 to have a material impact on its consolidated financial statements. Simplifying the Test for Goodwill Impairment In January 2017, the FASB issued ASU No. 2017-4 “Topic 350: Intangibles-Goodwill and Other: Simplifying the Test for Goodwill Impairment.” The amendments in this update eliminate step two of the goodwill impairment test and specifies that goodwill impairment should be measured by comparing the fair value of a reporting unit with its carrying amount. Additionally, the amount of goodwill allocated to each reporting unit with a zero or negative carrying amount of net assets should be disclosed. The amendments in this update are effective for annual or interim goodwill impairment tests performed in fiscal years beginning after December 15, 2019; early adoption is permitted. The Company does not expect the adoption of ASU 2017-4 to have a material impact on its consolidated financial statements. Share-based Compensation In May 2017, the FASB issued guidance on changes to terms and conditions of share-based payment awards. The amendment provides guidance about which changes to terms or conditions of a share-based payment award require an entity to apply modification accounting. The guidance is effective for the fiscal year beginning on January 1, 2018, including interim periods within that year. The Company does not anticipate that adoption of this guidance will have a material impact on its consolidated financial statements. Revenue Recognition In May 2014, the FASB issued guidance on revenue from contracts with customers that will supersede most current revenue recognition guidance, including industry-specific guidance. Under the new standard, a good or service is transferred to the customer when (or as) the customer obtains control of the good or service, which differs from the risk and rewards approach under current guidance. The guidance provides a five-step analysis of transactions to determine when and how revenue is recognized. Other major provisions include capitalization of certain contract costs, consideration of the time value of money in the transaction price and allowing estimates of variable consideration to be recognized before contingencies are resolved in certain circumstances. The guidance also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from an entity’s contracts with customers. In March, April and May 2016, the FASB issued three additional updates regarding identifying performance obligations and licensing, certain principal versus agent considerations and various narrow scope improvements based on practical questions raised by users. In September 2017, the FASB issued additional amendments providing clarification and implementation guidance. The guidance may be adopted through either retrospective application to all periods presented in the financial statements (full retrospective approach) or through a cumulative effect adjustment to retained earnings at the effective date (modified retrospective approach). The guidance is effective for the fiscal periods beginning on January 1, 2018. Leases In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”), which modifies lease accounting for lessees to increase transparency and comparability by recording lease assets and liabilities for operating leases and disclosing key information about leasing arrangements. The new standard is effective for interim and annual periods beginning after December 15, 2018 on a modified retrospective basis. The Company will adopt ASU 2016-02 in its first quarter of the year ending October 31 2020. The Company expects its leases designated as operating leases in Note 6, “Commitments and Contingencies,” will be reported on the consolidated balance sheets upon adoption. However, the ultimate impact of adopting ASU 2016-02 will depend on the lease terms as of the adoption date. The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoptions of any such pronouncements may be expected to cause a material impact on the financial condition or the results of operations.

Going Concern

Going Concern	6 Months Ended
	Apr. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 9 GOING CONCERN As reflected in the accompanying unaudited condensed consolidated financial statements, the Company has not commenced revenue producing operations and has an accumulated deficit of $8,110,660 as of April 30, 2018 and which includes a net loss of $431,362 for the six months ended April 30, 2018. As of April 30, 2018, the Company’s total current liabilities exceeded its total current assets by $5,731,478 and the Company used cash in operations of $406,484 for the six months ended on that date. These factors raise substantial doubt about its ability to continue as a going concern. In view of the matters described above, recoverability of a major portion of the recorded asset amounts shown in the accompanying condensed consolidated balance sheet is dependent upon continued operations of the Company, which in turn is dependent upon the Company’s ability to raise additional capital, obtain financing and succeed in its future operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management has taken the following steps to revise its operating and financial requirements, which it believes are sufficient to provide the Company with the ability to continue as a going concern. The Company is actively pursuing additional funding and strategic partners, which will enable the Company to implement its business plan. Management believes that these actions as successful will allow the Company to continue its operations through the next fiscal year.

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Apr. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Lease Obligations of Operating Leases	The schedule of future minimum lease obligations falling due under non-cancelable rental operating leases is as follows: Fiscal year ending October 31, 2018 7,580 Fiscal year ending October 31, 2019 7,580 Total $ 15,160

Organization (Details Narrative

Organization (Details Narrative) - USD ($)	Dec. 31, 2008	Jan. 29, 2008	May 31, 2007	Sep. 25, 2002
Masterise [Member]
Ownership interest - majority stockholder			63.00%
Ownership interest - minority stockholder			37.00%
Masterise [Member] | ABMT [Member]
Ownership acquired	100.00%
Stock issued in acquisition, shares	50,000
Shenzhen Changhua [Member]
Registered capital				$ 724,017
Ownership interest - majority stockholder				70.00%
Ownership interest - minority stockholder				30.00%
Shenzhen Changhua [Member] | Masterise [Member]
Ownership acquired		70.00%
Payment for acquisition		$ 64,100
Majority Shareholders [Member] | ABMT [Member]
Ownership acquired	80.70%
Stock sold per affiliate agreement, shares	5,001,000
Stock sold per affiliate agreement	$ 5,000
Majority Shareholders [Member] | Masterise [Member]
Stock sold per affiliate agreement, shares	4,438,250

Principles of Consolidation (De

Principles of Consolidation (Details Narrative)	Apr. 30, 2018
Accounting Policies [Abstract]
Ownership of subsidiaries	70.00%
Ownership by noncontrolling stockholders	30.00%

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 30, 2018	Apr. 30, 2017	Apr. 30, 2018	Apr. 30, 2017	Oct. 31, 2017
Due to stockholder	$ 669,571		$ 669,571		$ 582,795
Interest rate			7.00%		7.00%
Due to related parties	4,333,783		$ 4,333,783		$ 3,767,180
Interest paid to a stockholder and related parties	72,293	$ 56,317	139,839	$ 111,873
Due to directors	322,514		322,514		321,420
Imputed interest	$ 3,797	$ 3,927	$ 7,641	$ 8,020
Two Directors [Member]
Interest rate	5.00%	5.00%	5.00%	5.00%
Due to directors	$ 322,514		$ 322,514		$ 321,420
Imputed interest	3,797	$ 3,927	$ 7,641	$ 8,020
Three Related Parties [Member]
Interest rate			7.00%		7.00%
Due to related parties	$ 4,333,783		$ 4,333,783		$ 3,767,180

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Future Minimum Lease Obligations of Operating Leases (Details)	Apr. 30, 2018USD ($)
Commitments and Contingencies Disclosure [Abstract]
Fiscal year ending October 31, 2018	$ 7,580
Fiscal year ending October 31, 2019	7,580
Total	$ 15,160

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Apr. 30, 2018	Apr. 30, 2017	Apr. 30, 2018	Apr. 30, 2017	Oct. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 8,110,660		$ 8,110,660		$ 7,679,298
Net loss	208,819	$ 183,335	431,362	$ 337,448
Working capital deficit	$ 5,731,478		5,731,478
Net cash used in operating activities			$ 406,484	$ 190,673